Larry D. Anderson Jr., M.D. , PHD
NPI 1144267766ActiveIndividual· Internal Medicine, Medical Oncology· Dallas, TX
Internal Medicine, Medical Oncology (M.D. , PHD) in Dallas, Texas, trained at University of Texas Medical School at Houston (class of 2000). Their prescriptions cost Medicare Part D more than their services did: $16,078,022 for 2,703 claims, against $73,625 paid for services in 2024. Janssen Biotech, Inc. was the largest of 13 companies reporting payments in 2025, $17,456 in all, mostly consulting fees.
Overview
| NPI | 1144267766 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. , PHD |
| Sole proprietor | No |
| NPI issued | Jun 1, 2006 |
| Last updated in NPPES | May 22, 2019 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Medical Oncology Primary | 207RX0202X | N0607 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Hematopoietic Cell Transplantation and Cellular Therapy (TX) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 330 |
|---|---|
| Services billed | 692 across 11 procedure codes |
| Paid by Medicare | $73,625 |
Part D prescriptions in 2024
| Prescriptions (claims) | 2,703 · 3,353 30-day fills |
|---|---|
| Patients | 203 |
| Total drug cost | $16,078,022 |
| Generic share | 71% of claims |
Education and affiliations
| Medical school | University of Texas Medical School at Houston |
|---|---|
| Graduation year | 2000 |
| Medicare specialty | Hematopoietic Cell Transplantation And Cellular Therapy |
| Secondary specialties | Hematology/Oncology, Internal Medicine |
| Telehealth | Offers telehealth |
Medical group
- University of Texas Southwestern Medical Center at DallasDallas, TX · 3,187 clinicians
Hospital affiliation
Industry payments (Open Payments)
- 2025$17,456 · 27 payments from 13 companies
- 2024$12,404 · 24 payments from 7 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Janssen Biotech, Inc. | $6,822 | 11 |
| Kite Pharma, Inc. | $4,420 | 2 |
| E.R. Squibb & Sons, L.L.C. | $2,993 | 1 |
| Pfizer Inc. | $1,890 | 1 |
| Karyopharm Therapeutics Inc. | $323.88 | 2 |
What the 2025 payments were for
- Consulting Fee$15,185 · 5 payments
- Food and Beverage$1,707 · 20 payments
- Honoraria$305.63 · 1 payment
- Travel and Lodging$258.57 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Medical Oncology providers in Dallas
- 1750359519
- 1003083445
- 1922846617
- 1326288564
- 1508285313
- 1710299482
- 1902980014
- 1245277698
- 1235171281
- 1871535823
- 1821483009
- 1285676411
All Internal Medicine, Medical Oncology providers in Texas →